http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33188388

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article|Research Support, Non-U.S. Gov't
issn 0920-1211
pageRange 106561-
publicationName Epilepsy Research
startingPage 106561
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb18fe99130b8e9bb1f6902cafe0f49f
bibliographicCitation Hixson J, Gidal B, Pikalov A, Zhang Y, Mehta D, Blum D, Cantu D, Grinnell T; Study 701 Investigators. Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures. Epilepsy Res. 2021 Mar;171():106561. doi: 10.1016/j.eplepsyres.2021.106561. PMID: 33556737.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54f2771c33189de82c04c1b40b14eb79
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8f8f763037f2731664644d6e7d6e204
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8adee9db607d17dcb419a6d1b84defe4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ce4ff55fcc11e539dc33465564bcaba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e716da57f4c7d2c2998fae7ff9da1def
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7c22cd367fd0df9af91737e0ddc1e57
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32888fc314bb3bf12ade5c503ef636a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9954-9348
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26e028bab95c91dbc3cddfbdfd9a6c19
date 202103
identifier https://pubmed.ncbi.nlm.nih.gov/33556737
https://doi.org/10.1016/j.eplepsyres.2021.106561
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
https://portal.issn.org/resource/ISSN/0920-1211
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures
discusses http://id.nlm.nih.gov/mesh/M0006249
http://id.nlm.nih.gov/mesh/M0374531
http://id.nlm.nih.gov/mesh/M0374035
http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0137818
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D012640Q000188
http://id.nlm.nih.gov/mesh/D011788
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000077213Q000627
http://id.nlm.nih.gov/mesh/D003984Q000009
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D000927Q000009
http://id.nlm.nih.gov/mesh/D000077287Q000627
http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6654
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8592
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID179344
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284583
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3878

Total number of triples: 53.